← European Medicine Shortage Tracker · all medicines

Synalar shortage — availability across Europe

Synalar currently has availability issues reported in 1 European register: Spain.

MEDICALLY REVIEWED

Dr. Chrysoula I. Liakou MD, PhD

Internal Medicine Specialist
Cancer Immunology Researcher

Reviewed 30 July 2026 · next review due 30 January 2027

Shortage ATC — · also listed as: SYNALAR · data refreshed 7 August 2026

Key facts

As of 7 August 2026, Synalar has active availability issues in 1 of 10 tracked European registers.
Registers reporting issues: Spain.
Latest expected-resolution date on file: 2027-03-02.
Longest-running open report: since 2026-03-02 (5 months, Spain).
Data source: 1 official medicines-agency register, refreshed daily.

As of 7 August 2026, 1 of the 10 tracked registers list current availability issues for Synalar, covering 1 affected product presentation. The longest-running open report was filed in Spain on 2026-03-02 and has now been open for about 5 months. The furthest expected-resolution date currently on file is 2027-03-02; the earliest is 2027-03-02. Registers in Spain indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.

Where	Status & products	Since	Expected end	Reason / alternatives	Source
🇪🇸 Spain	Shortage SYNALAR 0,25 MG/G ESPUMA CUTANEA , 1 envase a presión de 60 g	2026-03-02	2027-03-02	Existen otros medicamentos con el mismo principio activo y misma vía. Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración.	register ↗

Full report history (1 register entry)

Every individual register entry for Synalar in the tracked sources, newest first — including resolved and discontinued reports.

Reg.	Product	Status	Reported	Expected end	Stated reason
🇪🇸 ES	SYNALAR 0,25 MG/G ESPUMA CUTANEA , 1 envase a presión de 60 g	Shortage	2026-03-02	2027-03-02	Existen otros medicamentos con el mismo principio activo y m

Frequently asked

Is Synalar currently in shortage in Europe?

Yes. As of 7 August 2026, availability issues are reported in: Spain. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Synalar shortage expected to end?

Agency prognoses on file range from 2027-03-02 to 2027-03-02. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Are there alternatives to Synalar?

1 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Synalar availability data come from?

Directly from the official medicines-agency register that lists Synalar: AEMPS CIMA (Spain). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Synalar — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/synalar/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Synalar availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/synalar/">Synalar shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>

Cite: “Synalar: availability status across 1 European registers — European Medicine Shortage Tracker (MobiDoctor), 7 August 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.